Page 165 - CW E-Magazine (18-3-2025)

News from Abroad

GEARED FOR GROWTH
CordenPharma plans new peptide facility

in Switzerland

Swiss CDMO, CordenPharma, has production technologies, ensuring com-
revealed plans to invest over Euro 500-mn pliance with the most stringent regula-
in building a new greenfield facility tions. The company expects the main
for small to large-scale peptide deve- construction and qualification phase to
lopment and manufacturing within the take place between 2025 and 2027 and
Basel region in Muttenz, Switzerland. start of commercial activities to begin in
the first half of 2028.
This follows the July 2024 an-
nouncement wherein the company had US expansion
unveiled plans to invest over Euro 1-bn In their Boulder, Colorado (US)
over the next 3 years in building and / facility, both expansions to existing lines
or expanding small, medium, and large and the construction of a new greenfield
peptide manufacturing facilities across production area have already begun in
Europe and the US. The company’s parallel to the Switzerland initiative.
expansion plans are set to propel its Pep- multiple manufacturing lines capable of The expansion will more than double
tide Platform business beyond the Euro supporting small, medium, and large- the existing SPPS reactor capacity at
1-bn sales milestone by 2028, reinforc- scale peptide production with small- to CordenPharma Colorado by adding an
ing CordenPharma’s position as a lead- large-scale Solid Phase Peptide Syn- additional 25,000-litre of SPPS capa-
ing player in integrated supply of small thesis (SPPS) reactors for GLP-1 and city – making it a total reactor capacity
to large-scale services from APIs to drug non-GLP-1 peptide projects – with a of >42,000-litre by 2028. CordenPharma
products, for both injectable and oral total SPPS reactor capacity of more than was acquired by Astorg, a leading
peptides. 5,000-litres. The new facility will fea- pan-European private equity firm, in
ture advanced automation, cutting-edge 2022 to accelerate its development
This Swiss investment will feature digitalisation, and innovative peptide plans.

INJECTION MOULDING
Engel expands in Mexico with new facility

Engel, Austria based leaders in our machines for custo- plan, Engel is implement-
manufacture of injection moulding mers across the region,” ing key upgrades, includ-
machines, is strengthening its market said Mr. Stefan Engleder, ing the further expansion
presence in the Americas with the CEO of Engel Group. of the flow-line manufac-
opening of a new production facility in turing system, and extended
Querétaro, Mexico. The company said the machining capabilities.
Querétaro facility also These improvements will
Engel said the newly acquired offers ample space for future expansion. optimise production efficiency while
facility provides it with the necessary “The decision to acquire this property maintaining the company’s quality
capacity and infrastructure to signifi- was made with long-term growth in standards. Engel said will manufacture
cantly scale up production. The faci- mind, ensuring that Engel can further the e-mac (all-electric small machine)
lity is designed to support a structured increase production capacity if market and Wintec t-win (hydraulic, two-platen
production flow, ensuring the flexibility demand continues to rise,” the company large machine) series, as well as custom
needed to adapt to evolving market de- said in a press note. The Querétaro faci- robots and automation solutions at this
mands. “This expansion allows us to lity will undergo a phased modernisation facility, ensuring a strong production
notably accelerate the start of produc- to align with Engel’s production stan- base for these high-demand machines in
tion, ensuring increased availability of dards. As part of a long-term investment the region.

Chemical Weekly March 18, 2025 165

Contents Index to Advertisers Index to Products Advertised